Effectiveness of Two-Year Clopidogrel + Aspirin in Abolishing the Risk of Very Late Thrombosis After Drug-Eluting Stent Implantation (from the TYCOON [Two-Year ClOpidOgrel Need] Study)

American Journal of Cardiology

Volumn 104, Issue 10, 2009, Pages 1357-1361

  Tanzilli, Gaetano ^a   Greco, Cesare ^a   Pelliccia, Francesco ^a,b   Pasceri, Vincenzo ^b   Barillà, Francesco ^a   Paravati, Vincenzo ^a   Pannitteri, Gaetano ^a   Gaudio, Carlo ^a   Mangieri, Enrico ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN FILIPPO NERI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CORONARY STENT; DRUG ELUTING STENT; DRUG WITHDRAWAL; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REGISTER; STENT THROMBOSIS; THROMBOSIS PREVENTION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ASPIRIN; CORONARY THROMBOSIS; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; REGISTRIES; STENTS; TICLOPIDINE; TIME FACTORS;

EID: 71749100657     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.07.002     Document Type: Article

References (22)

1. King III S.B., Smith Jr. S.C., Hirshfeld Jr. J.W., Jacobs A.K., Morrison D.A., Williams D.O., Feldman T.E., Kern M.J., O'Neill W.W., Schaff H.V., Whitlow P.L., Adams C.D., Anderson J.L., Buller C.E., Ceager M.A., Ettanger S.M., Halperin J.L., Hunt S.A., Krumholz H.M., Kushner F.G., Lytle B.W., Nishimura R., Page R.L., Riegel B., Tarkington L.G., Yancy C.W., and ACC/AHA/SCAI. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol 51 (2008) 172-209
2. Banerjee S., Varghese C., Samule J., Banerjee S., Varghese C., Samuel J., Weideman R.A., Little B.B., Kelly K.C., Rao S.V., Reilly R.F., and Brilakis E.S. Comparison of the impact of short (<1 year) and long term (> or =1 year) clopidogrel use following percutaneous coronary intervention on mortality. Am J Cardiol 102 (2008) 1159-1162
3. Butler M.J., Eccleston D., Clark D.J., Butler M.J., Eccleston D., Clark D.J., Ajani A.E., Andrianopoulos N., Brennan A., New G., Black A., Szto G., Reid C.M., Yan B.P., Shaw J.A., Dart A.M., Duffy S.J., and Melbourne Interventional Group. The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents. Am Heart J 157 (2009) 899-907
4. Maisel W.H. Unanswered questions; drug-eluting stents and the risk of late thrombosis. N Engl J Med 356 (2007) 981-984
5. Marzocchi A., Saia F., Piovaccari G., Manari A., Aurier E., Benassi A., Cremonesi A., Percoco G., Varani E., Magnavacchi P., Guastaroba P., Grilli R., and Maresta A. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry. Circulation 115 (2007) 3181-3188
6. Liistro F., and Colombo A. Late acute thrombosis after paclitaxel eluting stent implantation. Heart 86 (2001) 262-264
7. Kerner A., Gruberg L., Kapeliovich M., and Grenadier E. Late stent thrombosis after implantation of a sirolimus-eluting stent. Catheter Cardiovasc Interv 60 (2003) 505-508
8. Pasceri V., Pelliccia F., Cianfrocca C., Pristipino C., Santini M., and Richichi G. Very late thrombosis after sirolimus-eluting stent implantation. J Cardiovasc Med 7 (2006) 438-442
9. Biondi-Zoccai G.G., Lotrionte M., Agostoni P., Abbate A., Fusaro M., Burzotta F., Testa L., Sheiban I., and Sangiorgi G. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 27 (2006) 2667-2674
10. Mauri L., Hsieh W.H., Massaro J.M., Ho K.K., D'Agostino R., and Cutlip D.E. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356 (2007) 1020-1029
11. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined: a consensus document of the joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
12. Eisenstein E.L., Anstrom K.J., Kong D.F., Shaw L.K., Tuttle R.H., Mark D.B., Kramer J.M., Harrington R.A., Matchar D.B., Kandzari D.E., Peterson E.D., Schulman K.A., and Califf R.M. Clopidogrel use and long-term clinical outcome after drug-eluting stent implantation. JAMA 297 (2007) 159-168
13. Beohar N., Davidson C.J., Kip K.E., Goodreau L., Vlachos H.A., Meyers S.N., Benzuly K.H., Flaherty J.D., Ricciardi M.J., Bennett C.L., and Williams D.O. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA 297 (2007) 1992-2000
14. Doyle B., Rihal C.S., O'Sullivan C.J., Lennon R.J., Wiste H.J., Bell M., Bresnahan J., and Holmes Jr. D.R. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. Circulation 116 (2007) 2391-2398
15. Choi S.-H., Prasad A., and Tsimikas S. The evolution of thienopyridine therapy. J Am Coll Cardiol 51 (2008) 2228-2229
16. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., Airoldk F., Chieffo A., Montorfano M., Carlino M., Michev I., Corvaja N., Briguori C., Gerckens U., Grube E., and Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug eluding stents. JAMA 293 (2005) 2126-2130
17. Roy P., Bonello L., Torguson R., Okabe T., Pinto Slottow T.L., Steinberg D.H., Kaneshige K., Xue Z., Satler L.F., Kent K.M., Suddath W.O., Pichard A.D., Lindsay J., and Waksman R. Temporal relation between clopidogrel cessation and stent thrombosis after drug-eluting stent implantation. Am J Cardiol 103 (2009) 801-805
18. Park D.W., Yun S.C., Lee S.W., Kim Y.H., Lee C.W., Hong M.K., Cheong S.S., Kim J.J., Park S.W., and Park S.J. Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent: data from an observational cohort study of drug-eluting versus bare-metal stents. J Am Coll Cardiol Intv 1 (2008) 494-503
19. Pfistaer M., Brunner-La Rocca H.P., Buser P.T., Rickenbacher P., Hunziker P., Mueller C., JEger R., Bader F., Osswald S., Kaiser C., and BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
20. Spertus J.A., Kettelkamp R., Vance C., Decker B., Jones P.G., Rumsfeld J.S., Messenger J.C., Khanal S., Peterson E.D., Bach R.G., Krumholz H.M., and Cohun D.J. Prevalence, predictors and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER Registry. Circulation 113 (2006) 2803-2809
21. Dean J., Yujie Z., Yingxin Z., Yuyang L., Yonghe G., Wanjun C., and Zheng C. Prolonged dual antiplatelet therapy improves clinical outcomes in high-risk patients implanted with sirolimus-eluting stents. Clin Cardiol 32 (2009) 164-168
22. Angiolillo D.J. Variability in responsiveness to oral antiplatelet therapy. Am J Cardiol 103 suppl (2009) 27A-34A